OCX-410

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameOCX-410
Drug Alias NameOCX-410
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionChitinase-3-like protein 1 inhibitorsProgrammed cell death protein 1 blockersGlycoproteins stimulants
TargetsChitinase-3-like protein 1Programmed cell death protein 1Glycoproteins
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOcean Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesElkurt IncOcean Biomedical Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A